Freedman, Mark
NeuroRx Research (Canada) · Vrije Universiteit Amsterdam · Amsterdam UMC Location Vrije Universiteit Amsterdam
2 papers on CoChat
Most cited papers
- Verified
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Kappos, L., Bar-Or, A., Cree, B. A. C., Fox, R. J., Giovannoni, G., Gold, R., Vermersch, P., Arnold, D. L., Arnould, S., Scherz, T., et al. (2018) · The Lancet
Multiple Sclerosis Research StudiesSphingolipid Metabolism and Signaling
Cited by 942
- Verified
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life—A post hoc analysis of the TEMSO and TOWER studies
Mäurer, M., Comi, G., Freedman, M. S., Kappos, L., Olsson, T. P., Wolinsky, J. S., Miller, A. E., Dive-Pouletty, C., Bozzi, S., & O’Connor, P. W. (2016) · Multiple Sclerosis and Related Disorders
Multiple Sclerosis Research StudiesHealth Systems, Economic Evaluations, Quality of Life
Cited by 39
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free